Article
Incorporation of molecular data into the Revised International Prognostic Scoring System in treated patients with myelodysplastic syndromes.
Leukemia - 1 Nov 2016
Nazha A, Narkhede M, Radivoyevitch T, Seastone D J, Patel B J, Gerds A T, Mukherjee S, Kalaycio M, Advani A, Przychodzen B, Carraway H E, Maciejewski J P, Sekeres M A
Abstract excerpt
The Revised International Prognostic Scoring System (IPSS-R) was developed for untreated myelodysplastic syndrome (MDS) patients based on clinical data. We created and validated a new model that incorporates mutational data to improve the predictive capacity of the IPSS-R in treated MDS patients. Clinical and mutational data from treated MDS patients diagnosed between January 2000 and January 2012 were used to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.